| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |